(Q44822535)

6 December 2017

Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder (English)

1 reference

6 December 2017

0 references

1 reference

Sarah M Clinton

1

1 reference

6 December 2017

James H Meador-Woodruff

series ordinal

2

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

6 December 2017

Neuropsychopharmacology

1 reference

6 December 2017

29

1 reference

6 December 2017

7

1 reference

6 December 2017

1353-1362

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300451

6 December 2017

0 references

cites work

The role of the thalamus in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Activity-dependent regulation of N-methyl-D-aspartate receptor subunit expression in rat cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Neuroprotective effects of lithium in cultured cells and animal models of diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

The thalamus as a site of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

The glutamatergic dysfunction hypothesis for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Secondary mania with focal cerebrovascular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Altered magnetic resonance white-matter T1 values in patients with affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Regulated subcellular distribution of the NR1 subunit of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Thalamic volumes in patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Glutamate in schizophrenia: clinical and research implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Cloned glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Amelioration of negative symptoms in schizophrenia by glycine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Cortical development and thalamic pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Hippocampal abnormalities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Neuroanatomical substrates of depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Subnucleus-specific loss of neurons in medial thalamus of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Frontosubcortical neuroanatomy and the continuous performance test in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Ligand-gated ion channel interactions with cytoskeletal and signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Protein serine/threonine phosphatases--new avenues for cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

A functional neuroanatomy of hallucinations in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

The anatomy of mood disorders--review of structural neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Structural brain abnormalities in first-episode mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

Neurofilament-L Is a Protein Phosphatase-1-binding Protein Associated with Neuronal Plasma Membrane and Post-synaptic Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Bipolar affective disorder. I. Comprehensive quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Impaired attention in depressive states: a non-specific deficit?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

The calibration of 35S or 32P with 14C-labeled brain paste or 14C-plastic standards for quantitative autoradiography using LKB Ultrofilm or Amersham Hyperfilm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300451

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300451

1 reference

Dimensions Publication ID

6 December 2017

0 references

1 reference